MENU
+Compare
MIRA
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$1.73
Change
-$0.01 (-0.57%)
Capitalization
16.26M

MIRA MIRA Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders... Show more

MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MIRA with price predictions
Jul 25, 2025

MIRA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MIRA moved above the 200-day moving average on June 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 11, 2025. You may want to consider a long position or call options on MIRA as a result. In of 29 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MIRA just turned positive on July 14, 2025. Looking at past instances where MIRA's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

MIRA moved above its 50-day moving average on July 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MIRA crossed bullishly above the 50-day moving average on July 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRA advanced for three days, in of 65 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MIRA moved out of overbought territory on July 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 12 cases where MIRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MIRA broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MIRA entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.931) is normal, around the industry mean (5.632). P/E Ratio (0.000) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.000) settles around the average of (0.161) among similar stocks. MIRA's P/S Ratio (0.000) is slightly lower than the industry average of (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIRA is expected to report earnings to fall 9.09% to -10 cents per share on September 03

MIRA Pharmaceuticals MIRA Stock Earnings Reports
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.01
The last earnings report on May 28 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 407.38K shares outstanding, the current market capitalization sits at 16.26M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
7
Web
https://www.mirapharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DECK116.8511.91
+11.35%
Deckers Outdoor Corp
CXM9.210.17
+1.88%
Sprinklr
NYC13.55-0.03
-0.22%
American Strategic Investment Co
VIR5.65-0.11
-1.91%
Vir Biotechnology
ARBE1.56-0.04
-2.50%
Arbe Robotics Ltd

MIRA and Stocks

Correlation & Price change

A.I.dvisor tells us that MIRA and VRBCF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and VRBCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-0.57%
VRBCF - MIRA
14%
Poorly correlated
N/A
OGN - MIRA
10%
Poorly correlated
+1.39%
ABBV - MIRA
5%
Poorly correlated
-0.29%
JNJ - MIRA
5%
Poorly correlated
-0.74%
SNYNF - MIRA
5%
Poorly correlated
+4.11%
More